PRI Webinar: How COVID-19 and Big Government Crushed American Small Business

June 29, 2021
Sacramento, CA, USA
150320221647327535

Join Pacific Research Institute (PRI) for a special conversation between Carol Roth, New York Times bestselling author and PRI fellow and economist Wayne Winegarden, Ph.D. Roth will share details about her new book, The War on Small Business: How the Government Used the Pandemic to Crush the Backbone of America, the state of the economy under the Biden administration, how the Federal Reserve has changed the American economy, what’s next for American small business owners, and general economic policy. The webinar will be held on Zoom and registration is free.

 

Tuesday, June 29, 2021 via Zoom,
9 AM PST to 10:00 AM PST

 

Carol Roth

Carol Roth is a “recovering” investment banker, entrepreneur, TV pundit and host, and New York Times bestselling author of The Entrepreneur Equation.

She has worked in a variety of capacities across several industries, including currently as an outsourced CCO, a director on public and private company boards, and a strategic advisor. She advocates for small business, small government, and big hair. Her new book, The War on Small Business: How the Government Used the Pandemic to Crush the Backbone of America, Roth unveils the many abuses of power inflicted on small businesses during the COVID-19 pandemic.

 

Wayne Winegarden

Wayne Winegarden, Ph.D., is a senior fellow in business and economics as well as the Director of PRI’s Center for Medical Economics and Innovation.

Winegarden’s policy research explores the connection between macroeconomic policies and economic outcomes, with a focus on fiscal policy, the health care industry, and the energy sector. As Director of the Center for Medical Economics and Innovation, Winegarden spearheads research and advances policies that support the continued viability and vitality of the U.S. biomedical and pharmaceutical industries to the benefit of patients and overall economic growth.

Dr. Winegarden is also the Principal of an economic advisory firm that advises clients on the economic, business, and investment implications from changes in broader macroeconomic trends and government policies.

 

Tell Your Friends

Related

Modern,Medical,Research,Laboratory,With,Microscope,And,Test,Tubes,With

Trump Embraces Disastrous Most Favored Nation Drug Pricing

President Donald Trump gave American drug companies an ultimatum last month. Either they agree to adopt foreign-style price controls, or the administration “will deploy every ...
business econ title

Using The Government To Crush Competitors Harms Fans And The Economy

Cronyism and industrial policy are thriving to the detriment of our economic vibrancy. Consider that between 1960 and 2007 – right before the Great Recession ...
MoneyMapPharmacy

Tariffs Won’t Secure Our Drug Supply Chain—They’ll Break It

The Trump administration is considering massive “Section 232” tariffs on imported medicines from key U.S. allies, including the European Union, the United Kingdom, Switzerland, Japan, ...
Scroll to Top